drugset / Trial / NCT07413913

A Study in Healthy People or Otherwise Healthy With Overweight or Obesity to Compare 2 Formulations of Survodutide Given in Different Ways, Either as a Pre-filled Syringe or a Pen-like Injector

NCT07413913

Phase 1 Completed 56 enrolled Boehringer Ingelheim
RandomizedCrossoverOpen-labelTreatment

Summary

The goal of this study is to find out whether different formulations of survodutide given by different delivery methods is taken up in the body in a similar way. Participants visit the study site regularly. During study visits, the doctors collect information about participants' health. To assess the study endpoints, participants regularly have blood samples taken.

Timeline

Start
2026-03-03
Primary completion
2026-05-28
Completion
2026-06-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Survodutide Protein / enzyme biologic

Indications